Epidemiological and Clinical Insights into Acinetobacter baumannii: A Six-Year Study on Age, Antibiotics, and Specimens
Introduction A. baumannii, a resilient and opportunistic Gram-negative bacterium, has emerged as a significant healthcare-associated pathogen, posing formidable challenges in clinical settings worldwide.1,2 Recognized as one of the most formidable …